Literature DB >> 20304706

Monitoring antimalarial resistance: launching a cooperative effort.

Carol Hopkins Sibley1, Philippe J Guerin, Pascal Ringwald.   

Abstract

Current information on efficacy of antimalarials is crucial to provide early warning of resistance. A collaborative effort between the Global Malaria Program of the World Health Organization (WHO) and the WorldWide Antimalarial Resistance Network (WWARN) has recently been launched. The effort is planned as a collaboration with the scientific malaria community to create a global, comprehensive, and inclusive network that will provide quality-assured information on antimalarial drug resistance.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20304706     DOI： 10.1016/j.pt.2010.02.008

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN： 1471-4922


  9 in total

1.  Plasmodium falciparum isolates with increased pfmdr1 copy number circulate in West Africa.

Authors:  Benoit Witkowski; Marie-Laure Nicolau; Patrice Njomnang Soh; Xavier Iriart; Sandie Menard; Muriel Alvarez; Bruno Marchou; Jean-François Magnaval; Françoise Benoit-Vical; Antoine Berry
Journal:  Antimicrob Agents Chemother       Date:  2010-04-19       Impact factor: 5.191

Review 2.  Recent clinical and molecular insights into emerging artemisinin resistance in Plasmodium falciparum.

Authors:  Connor O'Brien; Philipp P Henrich; Neha Passi; David A Fidock
Journal:  Curr Opin Infect Dis       Date:  2011-12       Impact factor: 4.915

Review 3.  Monitoring antimalarial drug resistance: Applying lessons learned from the past in a fast-moving present.

Authors:  Carol Hopkins Sibley; Ric N Price
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-04-20       Impact factor: 4.077

Review 4.  Tools for surveillance of anti-malarial drug resistance: an assessment of the current landscape.

Authors:  Christian Nsanzabana; Djibrine Djalle; Philippe J Guérin; Didier Ménard; Iveth J González
Journal:  Malar J       Date:  2018-02-08       Impact factor: 2.979

5.  Individual responses to a single oral dose of albendazole indicate reduced efficacy against soil-transmitted helminths in an area with high drug pressure.

Authors:  Martin Walker; Piet Cools; Marco Albonico; Shaali M Ame; Mio Ayana; Daniel Dana; Jennifer Keiser; Leonardo F Matoso; Antonio Montresor; Zeleke Mekonnen; Rodrigo Corrêa-Oliveira; Simone A Pinto; Somphou Sayasone; Jozef Vercruysse; Johnny Vlaminck; Bruno Levecke
Journal:  PLoS Negl Trop Dis       Date:  2021-10-19

6.  A framework for assessing the risk of resistance for anti-malarials in development.

Authors:  Xavier C Ding; David Ubben; Timothy N C Wells
Journal:  Malar J       Date:  2012-08-22       Impact factor: 2.979

7.  Ex vivo anti-malarial drugs sensitivity profile of Plasmodium falciparum field isolates from Burkina Faso five years after the national policy change.

Authors:  Halidou Tinto; Léa N Bonkian; Louis A Nana; Isidore Yerbanga; Moussa Lingani; Adama Kazienga; Innocent Valéa; Hermann Sorgho; Hervé Kpoda; Tinga Robert Guiguemdé; Jean Bosco Ouédraogo; Petronella F Mens; Henk Schallig; Umberto D'Alessandro
Journal:  Malar J       Date:  2014-05-31       Impact factor: 2.979

8.  A genome wide association study of Plasmodium falciparum susceptibility to 22 antimalarial drugs in Kenya.

Authors:  Jason P Wendler; John Okombo; Roberto Amato; Olivo Miotto; Steven M Kiara; Leah Mwai; Lewa Pole; John O'Brien; Magnus Manske; Dan Alcock; Eleanor Drury; Mandy Sanders; Samuel O Oyola; Cinzia Malangone; Dushyanth Jyothi; Alistair Miles; Kirk A Rockett; Bronwyn L MacInnis; Kevin Marsh; Philip Bejon; Alexis Nzila; Dominic P Kwiatkowski
Journal:  PLoS One       Date:  2014-05-08       Impact factor: 3.240

9.  In vivo/ex vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso.

Authors:  Moussa Lingani; Léa Nadège Bonkian; Isidore Yerbanga; Adama Kazienga; Innocent Valéa; Hermann Sorgho; Jean Bosco Ouédraogo; Petronella Francisca Mens; Henk D F H Schallig; Raffaella Ravinetto; Umberto d'Alessandro; Halidou Tinto
Journal:  Malar J       Date:  2020-01-06       Impact factor: 2.979
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.